COMMUNIQUÉS West-GlobeNewswire

Sanofi : Déclaration des transactions sur actions propres
17/09/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
17/09/2018
Announcement no. 55/2018 17 September 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]
Virbac : Operating profit up sharply in the first half of 2018
17/09/2018
Operating profit up sharply in the first half of 2018 CONSOLIDATED DATA AS OF JUNE 30 in € million 2018 2017 2018/2017 Evolution Revenue 430.0 437.5 -1.7% Evolution at constant exchange rates +3.9% Evolution at constant [...]
Virbac :Résultat opérationnel du premier semestre 2018 en nette croissance
17/09/2018
Résultat opérationnel du premier semestre 2018 en nette croissance CHIFFRES CONSOLIDÉS AU 30 JUIN en millions € 2018 2017 Évolution 2018/2017 Chiffre d'affaires 430,0 437,5 -1,7% Évolution à taux de change constants +3, [...]
Virbac: Availability of the half-yearly financial report as of June 30, 2018
17/09/2018
Virbac: Availability of the half-yearly financial report as of June 30, 2018 Public release - September 17, 2018 Virbac announced today that the 2018 half-yearly financial report is now available and has been filed with [...]
Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2018
17/09/2018
Virbac : Mise à disposition du rapport financier semestriel au 30 juin 2018 Communiqué diffusé le 17 septembre 2018 La société annonce avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés [...]
Oxurion NV to present further scientific findings supporting therapeutic potential of THR-317 & THR-687 as promising new therapies for Diabetic Eye Disease at upcoming EURETINA 2018 in Vienna, Austria
17/09/2018
Leuven, Belgium, 17 September 2018 - Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases [...]
Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy
17/09/2018
Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on the development of [...]
Advanzeon Solutions Engages Hayden IR to Develop Comprehensive Investor Relations Program
17/09/2018
Focused on Increasing Awareness and Enhancing Shareholder Value TAMPA, Fla., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Advanzeon Solutions, Inc. (OTC: CHCR ) today announced that it has retained Hayden IR , a national investor [...]
CLS Holdings USA Executes Two Letters of Intent, which will provide the Opportunity to Enter the Rapidly Expanding Massachusetts Market
17/09/2018
LAS VEGAS, Sept. 17, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]
Phase 2 Ready Oncology Drug Receives FDA Orphan Drug Designation
17/09/2018
SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced that it received FDA orphan drug designation for its ATI-1123 chemotherapy drug product [...]
Medtronic Joins Catalyst CEO Champions For Change and Pledges to Accelerate Women Into Management and Board Seats
17/09/2018
Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality DUBLIN - September 17, 2018 - Medtronic plc (NYSE:MDT) today announced it has joined the Catalyst CEO Champions For [...]
ATW Tech Signs a Letter of Intent for the Divestiture of Its Atman Assets
17/09/2018
MONTREAL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today that its fully-owned subsidiary InformationTelcharge.com (‘Atman’) signed a letter of intent to divest some of its assets to Marie- [...]
ATW Tech signe une lettre d’intention pour la vente des actifs d’Atman
17/09/2018
MONTRÉAL, 17 sept. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la signature par sa filiale exclusive InformationTelcharge.com (« Atman ») visant la vente de [...]
Comprehensive Pharmacy Services Named Best Pharmacy Support Services Provider – USA
17/09/2018
Global Health and Pharma Recognizes Comprehensive Pharmacy Services in 2018 Healthcare & Pharmaceutical Awards MEMPHIS, Tenn., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Global Health & Pharma (GHP) has selected [...]
Avadim Technologies Announces Name Change To Avadim Health, Inc.
17/09/2018
Name Change To Reflect Company Vision – “To Take Healing To The Nations” ASHEVILLE, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced [...]
Transactions under Novozymes’ stock buyback program
17/09/2018
Please read the full announcement in the attached PDF Attachment 2018_54_Stock_Buybackprogram_EN
PSI’s Acquisition of KINEX Strengthens Company’s Position as an IT Leader
17/09/2018
ARLINGTON, Va., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI) is pleased to announce that it has acquired KINEX, Inc., a company in business for over 20 years providing mission-critical [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
17/09/2018
Villepinte (France), le 17 septembre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 [...]

Pages